Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sienna Biopharmaceuticals logo — company profile

Sienna Biopharmaceuticals

Founded 2010 United States Westlake Village, United States 11-50 employees Post Ipo Equity Total: $86.00M Biotechnology, Pharmaceutical

General Information

Company Name Sienna Biopharmaceuticals
Founded Year 2010
Location United States Westlake Village, United States +1
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Sienna Biopharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sienna Biopharmaceuticals

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company founded in 2010. The company is revolutionizing the field of biotechnology by focusing on the discovery, development, and commercialization of targeted, topical products in medical dermatology and aesthetics. Sienna Biopharmaceuticals is dedicated to introducing first-in-class solutions to the market. With headquarters in the United States, the company received a Post-IPO Equity investment on 03 August 2018. This investment further underscores the company's potential to make a significant impact in the biotechnology and pharmaceutical industries.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 03 Aug 2018
Series B •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		24 Apr 2017
Series A •••••• 2
Investor Investor
12 Jul 2016
Series A •••••• - 28 Apr 2016

Sienna Biopharmaceuticals Alternatives & Competitors

Sienna Biopharmaceuticals vs
Berbee
Berbee United States

and and and and and and and and and and and and and and and and and and and and and and and an...

Series A
123 employees
Internet
Sienna Biopharmaceuticals vs
Aerodyne Research
Aerodyne Research United States

Providing R&D services and cutting-edge aerosol, trace gas, and isotope analyzers for global environ...

Grant
105 employees
Energy, Renewable Energy
Sienna Biopharmaceuticals vs
All Language Alliance, Inc.
All Language Alliance, Inc. United States

Legal Translators, Deposition Interpreters; Legal Genealogy & Archival Research; Heir Search Service...

6 employees

FAQ About Sienna Biopharmaceuticals

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics.
Sienna Biopharmaceuticals was founded in 2010.
Sienna Biopharmaceuticals is headquartered in Westlake Village, United States.
Sienna Biopharmaceuticals operates in the following industries: Biotechnology, Pharmaceutical.
Sienna Biopharmaceuticals has approximately 11-50 employees.
Sienna Biopharmaceuticals has completed 4 funding rounds, raising a total of $86.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Sienna Biopharmaceuticals include Berbee, Aerodyne Research, All Language Alliance, Inc., K-Marine Engineering Pte Ltd , Forus Mühendislik. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sienna Biopharmaceuticals and Berbee are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sienna Biopharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes